EcoDrugPlus

Selectin L

Ensembl ID : ENSEEUG00000011664
Gene Symbol: SELL
1 External references
86 Possible Orthologues:

Selectin P

Ensembl ID : ENSEEUG00000011569
Gene Symbol: SELP
1 External references
119 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSEEUG00000013288
Gene Symbol: SERPINC1
1 External references
200 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSEEUG00000001985
Gene Symbol: SIGMAR1
1 External references
205 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSEEUG00000013370
Gene Symbol: SIRT1
1 External references
159 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSEEUG00000000874
Gene Symbol: SMO
1 External references
203 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 10

Ensembl ID : ENSEEUG00000001987
Gene Symbol: SCN10A
1 External references
302 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 11

Ensembl ID : ENSEEUG00000004406
Gene Symbol: SCN11A
1 External references
96 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 2

Ensembl ID : ENSEEUG00000014892
Gene Symbol: SCN2A
1 External references
130 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 3

Ensembl ID : ENSEEUG00000002086
Gene Symbol: SCN3A
1 External references
133 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 7

Ensembl ID : ENSEEUG00000011378
Gene Symbol: SCN7A
1 External references
85 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSEEUG00000004734
Gene Symbol: SCN8A
1 External references
276 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).